According to a UK review that happened on cosmetic procedures, injections to plump up the skin are a crisis waiting to happen.
Lasting harm can be caused by dermal fillers that are covered by same level of regulations.
Companies often put profits ahead of care in the cosmetic surgery and with this the cosmetic surgery had been `trivialised', as stated by the review.
There are certain measures as recommended by the review in order to protect patients well.
There is a boom in the cosmetic procedures industry and this ranges from breast implants to fillers. The worth of cosmetic industry in 2005 was £750m in the UK, in 2010 this reached £2.3bn and by 2015, it is expected to reach £3.6bn.
The pace however has not been followed by the regulations and patients have been left vulnerable due to this.
Non-surgical procedures are witnessing the maximum growth to take care of wrinkles, laser removal and Botox and this area has been considered as `almost entirely unregulated'.
The procedures need specialized expertise but they were being treated as having a lunchtime hairdressers' appointment and visiting common beauty parties.
According to a new Wired report, citing a disclosure by Apple, the data which Apple collects for making improvements to its voice-driven Siri service is anonymized, and is kept on the servers of the company for two years before it is discarded....
Austrian authorities have asked Turkey to extradite an Austrian arrested recently. He is wanted...
China-based device manufacturer ZTE has recently revealed that it has worked out a "strategic...
On Friday, Tesla Motors announced a few new perks for customers who own its Tesla Model S electric sedan; and also made some changes to the terms of its service agreement.
Unveiling the new perks for the owners of Model S, Tesla CEO Elon...
Willibald Cernko, the CEO of Bank Austria, said that 2012 was tough year for the banking sector...
Google Street View has recently published digital images of the devastation caused in the...
In a price-hike which took effect in the beginning of 2013, bigwig Israeli drug-manufacturer Teva Pharmaceutical Industries Ltd. increased the costs of Copaxone and Azilect, which are two leading brand drugs of the company.
The increase in...
After having commenced the roll out of the substantially...
The rapidly-growing field of digital assistants for...
Amid the rumors making rounds about the yet-to-be-...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).